Based on the cholinergic hypothesis, the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) and increment in ACh levels can improve the memory and cognitive functions in AD patients [6, 7]. The gene discussed is ACHE; the disease is Alzheimer disease.